ARS Pharmaceuticals Inc:Northland Capital 首次覆盖给予“跑赢大盘”评级,目标价25美元

美股速递
Apr 09

Northland Capital 近日宣布对 ARS Pharmaceuticals Inc 启动研究覆盖,并给予“跑赢大盘”的积极评级。该机构同时设定了25美元的目标股价,显示出对公司未来增长潜力的坚定信心。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10